相似文献
1
T-cell/histiocyte-rich large B-cell lymphoma.富于T细胞/组织细胞的大B细胞淋巴瘤
Haematologica. 2010 Mar;95(3):352-6. doi: 10.3324/haematol.2009.016931.
2
T-cell/histiocyte-rich large B-cell lymphoma associated with a near-tetraploid karyotype and complex genetic abnormalities.与近四倍体核型及复杂基因异常相关的富于T细胞/组织细胞的大B细胞淋巴瘤
APMIS. 2006 Jun;114(6):474-8. doi: 10.1111/j.1600-0463.2006.apm_458.x.
3
A case of pure red cell aplasia complicated with diffuse large B cell lymphoma, T-cell-rich/histiocyte-rich variant: effectiveness of rituximab and implications for a common immunopathogenic role of B lymphocytes.
Acta Haematol. 2005;113(3):194-7. doi: 10.1159/000084450.
4
Nodular lymphocyte-predominant Hodgkin lymphoma and T cell histiocyte-rich large B cell lymphoma: diagnosis in two monozygotic twins.结节性淋巴细胞为主型霍奇金淋巴瘤和富于T细胞/组织细胞的大B细胞淋巴瘤：一对同卵双胞胎的诊断
Histopathology. 2010 Jul;57(1):159-62. doi: 10.1111/j.1365-2559.2010.03585.x.
5
CD5+ T-cell/histiocyte-rich large B-cell lymphoma.富含CD5+ T细胞/组织细胞的大B细胞淋巴瘤
Mod Pathol. 2002 Oct;15(10):1051-7. doi: 10.1097/01.MP.0000027624.08159.19.
6
[T cell/histiocyte-rich large B cell lymphoma].富于T细胞/组织细胞的大B细胞淋巴瘤
Zhonghua Bing Li Xue Za Zhi. 2005 Jun;34(6):377-8.
7
T-cell/histiocyte-rich large B-cell lymphoma of stomach: a rare variant of gastric B cell lymphoma.胃富于T细胞/组织细胞的大B细胞淋巴瘤：胃B细胞淋巴瘤的一种罕见变异型
Tunis Med. 2017 Jul;95(7):504-505.
8
'T-cell-rich large B-cell lymphoma'-'histiocyte-rich, T-cell-rich large B-cell lymphoma'-'T-cell/histiocyte-rich large B-cell lymphoma': will we ever see the wood for the trees?“富于T细胞的大B细胞淋巴瘤”——“富于组织细胞、富于T细胞的大B细胞淋巴瘤”——“T细胞/组织细胞丰富的大B细胞淋巴瘤”：我们能看清本质吗？
Histopathology. 2002 Sep;41(3):269-71. doi: 10.1046/j.1365-2559.2002.01354.x.
9
T-cell/histiocyte-rich large B-cell lymphoma of stomach.胃富于T细胞/组织细胞的大B细胞淋巴瘤
J Pak Med Assoc. 2016 Jul;66(7):905-7.
10
Pathology case quiz 2. Diffuse large B-cell lymphoma, T-cell/histiocyte-rich morphological variant, of the hard palate.
Arch Otolaryngol Head Neck Surg. 2010 Feb;136(2):205; 207-8. doi: 10.1001/archoto.2009.228-a.
引用本文的文献
1
Pediatric T-Cell/Histiocyte-Rich Large B-Cell Lymphoma (THRLBC) in an 8-Year-Old Male Child: A Case Report.一名8岁男童的小儿T细胞/组织细胞丰富型大B细胞淋巴瘤（THRLBC）：病例报告
Case Rep Oncol Med. 2025 Feb 22;2025:8869045. doi: 10.1155/crom/8869045. eCollection 2025.
2
Catch the Calcium: T-Cell Histiocyte-Rich B-Cell Lymphoma Presenting as Hypercalcemia.捕捉钙元素：以高钙血症为表现的富于T细胞/组织细胞的B细胞淋巴瘤
World J Oncol. 2023 Dec;14(6):570-574. doi: 10.14740/wjon1610. Epub 2023 Oct 21.
3
Epstein-Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma.爱泼斯坦-巴尔病毒与弥漫性大B细胞淋巴瘤的发病机制
Life (Basel). 2023 Feb 14;13(2):521. doi: 10.3390/life13020521.
4
Primary splenic T-cell/histiocyte-rich B-cell lymphoma in a patient with recurrent hairy cell leukemia: a case report.一名复发性毛细胞白血病患者的原发性脾富含T细胞/组织细胞的B细胞淋巴瘤：病例报告
Oxf Med Case Reports. 2022 Nov 24;2022(11):omac123. doi: 10.1093/omcr/omac123. eCollection 2022 Nov.
5
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade.在 THRLBCL 中鉴定 TCF1+ 祖细胞耗竭 T 细胞可能预测对 PD-1/PD-L1 阻断的更好反应。
Blood Adv. 2022 Aug 9;6(15):4634-4644. doi: 10.1182/bloodadvances.2022007046.
6
Splenic Micronodular T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: The Corticosteroid Pretreatment Hypothesis.脾脏微小结节性 T 细胞/组织细胞丰富的大 B 细胞淋巴瘤：皮质激素预处理假说。
Acta Haematol. 2022;145(3):310-317. doi: 10.1159/000520791. Epub 2021 Nov 9.
7
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.T细胞/组织细胞丰富的大B细胞淋巴瘤对CD19导向的嵌合抗原受体T细胞疗法的原发性耐药
Blood. 2021 Jun 17;137(24):3454-3459. doi: 10.1182/blood.2020009148.
8
Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data Base.T 细胞/组织细胞丰富型大 B 细胞淋巴瘤患者的临床特征和生存分析：国家癌症数据库分析。
Leuk Lymphoma. 2019 Dec;60(14):3426-3433. doi: 10.1080/10428194.2019.1639166. Epub 2019 Jul 9.
9
Diagnosis of Hodgkin lymphoma in the modern era.现代时代霍奇金淋巴瘤的诊断。
Br J Haematol. 2019 Jan;184(1):45-59. doi: 10.1111/bjh.15614. Epub 2018 Nov 8.
10
T-cell/histiocyte-rich large B-cell lymphoma in a child: A case report and review of literature.儿童富于T细胞/组织细胞的大B细胞淋巴瘤：一例报告并文献复习
World J Clin Cases. 2018 Jun 16;6(6):121-126. doi: 10.12998/wjcc.v6.i6.121.
本文引用的文献
1
T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response.T 细胞/组织细胞丰富性大 B 细胞淋巴瘤表现出提示耐受宿主免疫反应的转录特征。
Haematologica. 2010 Mar;95(3):440-8. doi: 10.3324/haematol.2009.009647. Epub 2009 Oct 1.
2
Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma.在结节性淋巴细胞为主型霍奇金淋巴瘤中，编码 NF-κB 调节因子 IκBα 和 A20 的基因突变并不常见。
Haematologica. 2010 Jan;95(1):153-7. doi: 10.3324/haematol.2009.010157. Epub 2009 Jul 31.
3
Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome.经典型霍奇金淋巴瘤组织的分子谱分析揭示了肿瘤微环境的变化以及与EB病毒感染和预后的相关性。
Blood. 2009 Mar 19;113(12):2765-3775. doi: 10.1182/blood-2008-07-168096. Epub 2008 Dec 18.
4
Stromal gene signatures in large-B-cell lymphomas.大B细胞淋巴瘤中的基质基因特征
N Engl J Med. 2008 Nov 27;359(22):2313-23. doi: 10.1056/NEJMoa0802885.
5
Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis.通过全基因表达分析揭示的结节性淋巴细胞为主型霍奇金淋巴瘤的起源与发病机制
J Exp Med. 2008 Sep 29;205(10):2251-68. doi: 10.1084/jem.20080809. Epub 2008 Sep 15.
6
PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.程序性死亡蛋白1（PD-1），一种有助于识别结节性淋巴细胞为主型霍奇金淋巴瘤的滤泡性T细胞标志物。
Am J Surg Pathol. 2008 Aug;32(8):1252-7. doi: 10.1097/PAS.0b013e318165b0d6.
7
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.弥漫性大B细胞淋巴瘤的分子谱分析确定了多种明确的亚型，其中一种以宿主炎症反应为特征。
Blood. 2005 Mar 1;105(5):1851-61. doi: 10.1182/blood-2004-07-2947. Epub 2004 Nov 18.
8
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.基于肿瘤浸润免疫细胞分子特征预测滤泡性淋巴瘤的生存率
N Engl J Med. 2004 Nov 18;351(21):2159-69. doi: 10.1056/NEJMoa041869.
9
10
Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.反应性B细胞群体、B细胞非霍奇金淋巴瘤和霍奇金淋巴瘤中鸸鹋增强子活性差异以及BOB.1/OBF.1、Oct2、PU.1和免疫球蛋白的表达
J Pathol. 2004 Jan;202(1):60-9. doi: 10.1002/path.1485.
Zotero 插件